Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs

• The obesity medications will be made available to both MangoRx and PeachesRx customers through Eli Lilly’s LillyDirect Self-Pay Pharmacy Solutions and Novo Nordisk’s NovoCare Pharmacy.
• The drugs will be available for home delivery for as low as $499 per month, the company said.

Shares of Mangoceuticals, Inc. (MGRX) jumped 23% in the pre-market session on Thursday after the telehealth company announced the launch of programs that provide direct access to authentic weight loss medicines from drugmakers Eli Lilly and Novo Nordisk.

The company said that it has launched two programs called MangoRx Direct and PeachesRx Direct to provide direct access to Lilly’s Zepbound and Novo’s Wegovy medicines.

How Will The Partnership Work?

Customers can receive virtual consultations with providers on Mangoceuticals’ telehealth platform and get personalized obesity and weight management plans and also get their GLP-1 medicines delivered to them.

The obesity medications will be made available to both MangoRx and PeachesRx customers through Eli Lilly’s LillyDirect Self-Pay Pharmacy Solutions and Novo Nordisk’s NovoCare Pharmacy. Both NovoCare and LillyDirect are aimed at providing medicines direct-to-consumer. While LillyDirect was launched last year, NovoCare was started earlier this year.

The drugs will be available for home delivery for as low as $499 per month, the company said. Customers can also opt to pick up their prescriptions at a neighborhood pharmacy of their choice.

“No insurance is required, making the programs ideal for self-pay, uninsured, underinsured and high-deductible patients,” Mangoceuticals CEO Jacob Cohen said.

How Did Stocktwits Users React?

On Stocktwits, retail sentiment around MGRX stock stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.

MGRX stock is down by 27% this year and by 28% over the past 12 months. 

Also See: MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal

For updates and corrections, email newsroom[at]stocktwits[dot]com

Share

·

Add us on